Vanda Pharmaceuticals Inc. VNDA
$5.71
▼ -3.77% 24H
About
Vanda Pharmaceuticals Inc. is a biopharmaceutical company focused on the development and commercialization of therapies addressing high unmet medical needs in areas such as sleep-wake disorders, psychiatric and neurologic conditions, motion sickness, inflammatory skin diseases, and gastrointestinal or treatment-related…
SectorHealthcare
ExchangeNASDAQ
IndustryBiotechnology
CountryUnited States
Employees368
TickerVNDA
Statistics
Market Cap$343.7M
Revenue (TTM)$216.1M
Net Income-$220.5M
Net Margin-102.0%
EPS$-4.06
P/E126.00
P/S1.67
P/B1.09
EV/EBITDA-1.14
ROE-60.5%
Dividend Yield—
Price$5.71
Data: Twelve Data · Revenue = mcap / P/S